Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06069778 |
| Title | Safety, Tolerability, and Efficacy of mFOLFIRINOX +/- BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | BioNTech SE |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Valkyrie Clinical Trials | RECRUITING | Los Angeles | California | 90067 | United States | Details |
| Clinical Research Alliance | RECRUITING | Westbury | New York | 11590 | United States | Details |
| Prisma Health Cancer Institute | RECRUITING | Greenville | South Carolina | 29605 | United States | Details |